OS Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update

OS Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update August 19, 2025 6:00 AM EDT | Source: OS Therapies New York, New York--(Newsfile Corp. - August 19, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported second quarter 2025 financial results ended June 30, 2025 and provided a business update. End of Phase 2 Meeting with FDA scheduled for A ...